Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 6Pancreatic Neoplasms 2Ovarian Neoplasms 2Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Stomach Neoplasms 1Peritoneal Neoplasms 1Neoplasms by Site 1Neoplasm Metastasis 1Liver Neoplasms 1Liver Diseases 1Hemangiosarcoma 1Gynecologic Cancer 1Digestive System Neoplasms 1Carcinoma, Transitional Cell 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1

Interventions

Surveys and Questionnaires 2Standard of Care 2Drug Therapy 2Brachytherapy 2genexol-PM 1gadobutrol 1fosaprepitant 1Therapeutics 1Surgical Procedures, Operative 1Sex 1Radiotherapy, Intensity-Modulated 1Psychotherapy 1Prochlorperazine 1Preoperative Exercise 1Population Groups 1Ondansetron 1Olanzapine 1Neurokinin-1 Receptor Antagonists 1NK Cell Lectin-Like Receptor Subfamily B 1Imagery, Psychotherapy 1FloSeal Matrix 1Ferric Oxide, Saccharated 1Exercise 1Enhanced Recovery After Surgery 1Educational Status 1Diagnostic Tests, Routine 1Diagnostic Imaging 1Dexamethasone 1Cryotherapy 1Counseling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gynecologic Cancer × genexol-PM × Clear all
NCT02739529 2017-05-01

Study to Evaluate the Efficacy and Safety of Genexol-PM Once a Week for Gynecologic Cancer

Samyang Biopharmaceuticals Corporation

Phase 1 Unknown
18 enrolled
Gynecologic

Gynecologic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡